Trials / Unknown
UnknownNCT02162966
Safety and Efficacy Study of High Dose Colistin
Use Of High Dose Colistin in Multi Drug Resistant Gram Negative Infections in Critically Ill Adult Patients. Randomized Controlled Clinical Trial
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 330 (estimated)
- Sponsor
- King Saud Medical City · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Colistin is a rapidly acting bactericidal antimicrobial agent that possesses a post antibiotic effect against MDRO Gram-negative bacteria, such as as Pseudomonas aeruginosa, Acinetobacterbaumannii, and Klebsiella pneumonia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | High Dose Colistin | High Dose Colistin |
| DRUG | Standard Dose Colistin | Standard Dose Colistin |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2016-10-01
- Completion
- 2016-10-01
- First posted
- 2014-06-13
- Last updated
- 2015-04-01
Locations
1 site across 1 country: Saudi Arabia
Source: ClinicalTrials.gov record NCT02162966. Inclusion in this directory is not an endorsement.